New York, April 25, 2024 - PRISM MarketView - Predictive Oncology Inc. (POAI) has announced that an abstract has been accepted for presentation at the 2024 American Society of Clinical Oncology Annual Meeting in Chicago. The meeting will take place from May 31st – June 4th. The study used multi-omic machine learning models to attempt to better predict short- and long-term survival outcomes in females with high grade sesrous ovarian cancer (HGSC) compared to clinical data alone. This study was in collaboration with UPMC Magee-Womens Hospital in Pittsburgh, PA.
The company participates in the PRISM NextGen Tech and AI Index and is currently up ~26%.
About PRISM MarketView
Established in 2020, PRISM MarketView is dedicated to the monitoring and analysis of small cap stocks in burgeoning sectors. We deliver up-to-the-minute financial market news, provide comprehensive investor tools and foster a dynamic investor community. Central to our offerings are proprietary indexes that observe emerging sectors, including biotech, clean energy, next-generation tech, medical devices and beyond. Visit us at prismmarketview.com and follow us on Twitter.
Disclaimer:
PRISM MarketView is not a registered or licensed broker-dealer or investment adviser and does not offer investment advice. The information provided in this communication is not intended to constitute an offer to sell, a solicitation of an offer to buy, or a recommendation for any security.
Contact:
Prism MarketView | Stock Market News & Investment Opportunities
PRISM MarketView - Social Media (X)